REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact
News
Sean Wattegedera (MRI) presented research from his group at the Friedrich Loeffler Institute
Sean Wattegedera, the Chlamydia abortus disease lead on REPRODIVAC presented research from his group (Moredun Research Institute) at the Friedrich Loeffler Institute, Jena as part of their invited external speaker seminar series. The presentation covered recent in vitro work chlamydial pathogenesis for the intermediate 84/2334 strain (BBSRC Responsive Mode) and advances towards the development of new vaccines to ovine enzootic abortion (REPRODIVAC InnovateUK/EU and RESAS Scottish Government). Thank you Christian Menge (REPRODIVAC Consortium colleague), Christiane Schnee and Elisabeth Lieber-Tenorio for hosting and leading discussions about future collaborative opportunities
Sean Wattegedera (MRI)
REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.
REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.